These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7093189)
1. Reactions of alpha-chymotrypsin with 4-(trifluoromethyl)-alpha-bromoacetanilide. Ando ME; Gerig JT Biochemistry; 1982 May; 21(10):2299-304. PubMed ID: 7093189 [TBL] [Abstract][Full Text] [Related]
2. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue. Cheon HG; Boteju LW; Hanna PE Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555 [TBL] [Abstract][Full Text] [Related]
3. Alkylation of amide linkages and cleavage of the C chain in the enzyme-activated-substrate inhibition of alpha-chymotrypsin with N-nitrosamides. Donadio S; Perks HM; Tsuchiya K; White EH Biochemistry; 1985 May; 24(10):2447-58. PubMed ID: 4016069 [TBL] [Abstract][Full Text] [Related]
4. Motion at the active site of [(4-fluorophenyl)sulfonyl]chymotrypsin. Ando ME; Gerig JT; Luk KF Biochemistry; 1986 Aug; 25(17):4772-8. PubMed ID: 3768312 [TBL] [Abstract][Full Text] [Related]
5. Proton and fluorine nuclear magnetic resonance spectroscopic observation of hemiacetal formation between N-acyl-p-fluorophenylalaninals and alpha-chymotrypsin. Gorenstein DG; Shah DO Biochemistry; 1982 Sep; 21(19):4679-86. PubMed ID: 7138821 [TBL] [Abstract][Full Text] [Related]
6. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin. Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865 [TBL] [Abstract][Full Text] [Related]
7. ESR probing of macromolecules: spin label study of the conformational integrity and transitions in modified alpha-chymotrypsin. Kosman DJ; Piette LH Arch Biochem Biophys; 1972 Apr; 149(2):452-60. PubMed ID: 4353584 [No Abstract] [Full Text] [Related]
8. Study of a sulfonyl derivative of alpha-chymotrypsin by chlorine nuclear magnetic resonance. Marshall AG Biochemistry; 1968 Jun; 7(6):2450-3. PubMed ID: 5660065 [No Abstract] [Full Text] [Related]
9. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid complex at pH 7. Sylvia LA; Gerig JT Biochim Biophys Acta; 1995 Oct; 1252(2):225-32. PubMed ID: 7578227 [TBL] [Abstract][Full Text] [Related]
10. Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)borates. Smoum R; Rubinstein A; Srebnik M Org Biomol Chem; 2005 Mar; 3(5):941-4. PubMed ID: 15731882 [TBL] [Abstract][Full Text] [Related]
11. pH dependence of the inhibition of chymotrypsin by a peptidyl trifluoromethyl ketone. Brady K; Liang TC; Abeles RH Biochemistry; 1989 Nov; 28(23):9066-70. PubMed ID: 2605240 [TBL] [Abstract][Full Text] [Related]
12. Evidence for hemiacetal formation between N-acyl-L-phenylalaninals and alpha-chymotrypsin by cross-saturation nuclear magnetic resonance spectroscopy. Chen R; Gorenstein DG; Kennedy WP; Lowe G; Nurse D; Schultz RM Biochemistry; 1979 Mar; 18(5):921-6. PubMed ID: 420824 [TBL] [Abstract][Full Text] [Related]
13. Structural and steric specificity of alpha-chloroketones as inhibitors of alpha-chymotrypsin. Kumar S; Hein GE Biochim Biophys Acta; 1970 Jun; 206(3):404-13. PubMed ID: 5459549 [No Abstract] [Full Text] [Related]
14. Specific modification of methionine-192 of -chymotrypsin by an affinity label exploiting the orienting properties of the linear acetylenic group. Jones JB; Hysert DW Biochemistry; 1972 Jul; 11(14):2726-33. PubMed ID: 5045526 [No Abstract] [Full Text] [Related]
15. Preparation and 13C NMR characterization of [[epsilon-13C] methionine-192]-alpha-chymotrypsin. The demethylation of [S-[13C] methylmethionine-192]-alpha-chymotrypsin by an active site-directed thiol. Matta MS; Henderson PA; Patrick TB J Biol Chem; 1981 May; 256(9):4172-4. PubMed ID: 7217077 [TBL] [Abstract][Full Text] [Related]
16. Enzyme-inhibitor interactions studies via fluorine nuclear magnetic resonance. I. The interaction of alpha-chymotrypsin with DL-N-trifluoroacetylphenylalanie. Zeffren E; Reavill RE Biochem Biophys Res Commun; 1968 Jul; 32(1):73-80. PubMed ID: 5672545 [No Abstract] [Full Text] [Related]
17. Evidence for multiple forms of p-trifluoromethylbenzenesulfonyl-alpha-chymotrypsin. Ando ME; Gerig JT; Luk KF; Roe DC Can J Biochem; 1980 May; 58(5):427-33. PubMed ID: 7407679 [TBL] [Abstract][Full Text] [Related]
18. Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. Liang TC; Abeles RH Biochemistry; 1987 Dec; 26(24):7603-8. PubMed ID: 3427096 [TBL] [Abstract][Full Text] [Related]
19. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4. O'Sullivan DB; O'Connell TP; Mahon MM; Koenig A; Milne JJ; Fitzpatrick TB; Malthouse JP Biochemistry; 1999 May; 38(19):6187-94. PubMed ID: 10320347 [TBL] [Abstract][Full Text] [Related]
20. Decreased reactivity of organophosphorus inhibitors towards a modified chymotrypsin. Thompson AR; Ellin RI Biochim Biophys Acta; 1970 Oct; 220(1):101-7. PubMed ID: 5472716 [No Abstract] [Full Text] [Related] [Next] [New Search]